基线肠道微生物群概况会影响抑郁症患者的治疗反应
Yingjing Xie1, Hanwen Zhu1, Yanling Yuan2
1West China Hospital, Sichuan University, Chengdu, China.
Frontiers in microbiology
|July 18, 2024
概括
肠道微生物群的组成在抑郁症患者中不同,并影响治疗反应. 了解这些肠道微生物组的变化可能会导致针对肠道健康的新型抑郁疗法.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 精神病学是一个精神病学.
背景情况:
- 肠道微生物群在抑郁症病理生理学中起着作用,与健康对照相比,抑郁症患者的微生物特征不同.
- 肠道微生物组影响中枢神经系统,免疫系统和神经内分泌调节.
- 在患有抑郁症的患者中观察到肠道微生物群的改变,因治疗反应而有所不同.
研究的目的:
- 审查在抑郁症患者之间肠道微生物群的差异,这些患者在抗抑郁药物治疗后实现了缓解,而不是那些没有实现缓解的人.
- 探索将肠道微生物组变化与抗抑郁药耐药性联系起来的潜在机制.
- 为开发向肠道微生物群的抑郁症治疗提供基础.
主要方法:
- 文学综述比较抑郁症患者的肠道微生物群的研究,治疗结果各不相同.
- 分析涉及肠道微生物群对免疫和神经系统的影响机制.
- 检查微生物组在酶活性,生物积累和血脑屏障功能中的作用.
主要成果:
- 在抑郁症患者和健康对照者之间,基线肠道微生物概况有所不同.
- 肠道微生物群的组成在治疗抗抑郁药后实现缓解和非缓解的患者之间有所不同.
- 肠道微生物组影响着与抑郁症和治疗反应相关的系统过程.
结论:
- 肠道微生物群与抑郁症有关,并影响抗抑郁药物的疗效.
- 机制包括微生物组对免疫系统,中枢神经系统和血脑屏障的影响.
- 准肠道微生物群是一个潜在的抑郁症治疗策略.
更多相关视频
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
9.6K
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
13.0K
相关概念视频
Anatomy of the Intestines
71.7K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.7K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome I: Introduction
264
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264
Depression: Overview
231
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
231
